Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.

Efpeglenatide once weekly and once every 2 wk led to significant body weight reduction and improved glycaemic and lipid variables versus placebo. It was also well tolerated for weight management in adults without diabetes.